Linezolid resistant coagulase negative staphylococci (LRCoNS) with novel mutations causing blood stream infections (BSI) in India

BACKGROUND: Coagulase-negative Staphylococci (CoNS) have emerged as a major causative agent of blood-stream infections (BSI). Linezolid (LZD) is currently used for treating glycopeptide and methicillin-resistant staphylococci. It is important to understand the resistance mechanism and probable trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Gajanand, Bhandari, Vasundhra, Gaind, Rajni, Rani, Vandana, Chopra, Shimpi, Dawar, Reetika, Sardana, Raman, Verma, P. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694603/
https://www.ncbi.nlm.nih.gov/pubmed/31412801
http://dx.doi.org/10.1186/s12879-019-4368-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694603/
https://www.ncbi.nlm.nih.gov/pubmed/31412801
http://dx.doi.org/10.1186/s12879-019-4368-6

Ejemplares similares